Alves, Ana Catarina2016-09-302016-09-302016-01http://hdl.handle.net/10400.18/4004The familial dyslipidaemia are underdiagnosed and so it is necessary an effort from all health professional to identify these high risk patients in order to provide the best counseling and treatment to reduce their elevated cardiovascular(hepatic/neurologic) risk. A novel diagnosis method (by NGS) is being implemented in order to study a larger panel of genes for dyslipidaemia to improve patient diagnosisengDoenças Cardio e Cérebro-vascularesDislipidémias FamiliaresDiagnóstico MolecularFamilial Dyslipidaemialecture